Slide 1: Corporate Presentation March 2016
Corporate Presentation March 2016 OTCQB: OPRX
Slide 2: Important Cautions Regarding Forward Looking Statements
OTCQB: OPRX This presentation contains forward - looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward - looking statements should not be used to make an investment decision. The wo
Slide 3: Key Stats (OTCQB: OPRX)
OTCQB: OPRX $1.1 $2.0 $4.7 $6.5 $7.2 2011 2012 2013 2014 2015 Annual Revenue $ millions Stock Price (3/9/2016 ) $0.97 52 Week Low - High $0.76 - $1.40 Avg. Daily Vol. (30 day) 24,980 Shares Outstanding 29.0M Public Float, est. 31% Insider Holdings ~35% Institutional Holdings 1 ~32% Market Cap $28.1M
Slide 4: Who We Are
OTCQB: OPRX Who We Are • We provide a unique SaaS platform that helps doctors and pharmaceutical companies deliver more affordable and compliant healthcare • Our flagship product, SampleMD ™ , provides physicians with electronically - dispensed vouchers and copay coupons right within their ePrescrib
Slide 5: Major Changes Effecting U.S. Pharma Market: Prescriber Access
OTCQB: OPRX Samples Declining EHR/ ePrescribing Rising Rx Co - Pay Decreased accessibility = less productive sale calls In 2015, pharmaceutical companies wasted $1 Billion - $1.5 billion annually on “infeasible” calls Prescriber Access 5 Major Changes Effecting U.S. Pharma Market 77% 78% 67% 64% 65%
Slide 6: Major Changes Effecting U.S. Pharma Market: Samples Declining
OTCQB: OPRX Prescriber Access Rising Rx Co - Pay EHR/ ePrescribing Samples Declining 6 Major Changes Effecting U.S. Pharma Market $4B samples market shifting to other areas of more effective patient support, including free trial vouchers & copay discounts Source: Medical Economics, “Saying no to sam
Slide 7: Major Changes Effecting U.S. Pharma Market: ePrescribing
OTCQB: OPRX Samples Declining Prescriber Access Rising Rx Co - Pay EHR / ePrescribing By 2016, estimated prescriptions will be electronically sent per year (a tipping point) & growing thereafter 2 billion 7 Major Changes Effecting U.S. Pharma Market [VALUE] M [VALUE] M 2 Billion [VALUE] M [VALUE] M
Slide 8: Major Changes Effecting U.S. Pharma Market: Rising Rx Co-Pay
OTCQB: OPRX Prescriber Access Samples Declining EHR/ ePrescribing Rising Rx Co - Pay 8 Major Changes Effecting U.S. Pharma Market Patient not filling Rx due to rising copay costs! $9 $18 $32 $11 $31 $53 $83 1st-Tier Drugs (Generic) 2nd-Tier Drugs (Preferred) 3rd-Tier Drugs (Nonpreferred) 4th-Tier Dr
Slide 9: OptimizeRx Targets Doctor's Most Valued Pharma Offering
OTCQB: OPRX OptimizeRx Targets Doctor’s Most Valued Pharma Offering: Drug Savings Vouchers & Co - Pay Coupons 9 Providers Who Value Vouchers or Coupons as Important Cardiologists 82% Endocrinology/ Diabetology 82% General Practice & Family Practice 85% Internal Medicine 80% Neurology 73% Oncology 74
Slide 10: How It Works
OTCQB: OPRX SampleMD automatically displays savings alert message to doctors upon product selection □ EHR sends electronic request to SampleMD when doctor selects a medication with our coupon We check eligibility & send uniquely identifiable savings to doctor within 1 second OptimizeRx Proprieta
Slide 11: Workflow Overview: Step 1 Search
OTCQB: OPRX Step 2: Selection Step 3: Print or Text Step 1: Search 11 Workflow Overview Health care provider searches for a brand within EHR and is alerted of potential savings availability for patient
Slide 12: Workflow Overview: Step 2 Selection
OTCQB: OPRX Step 2: Selection Step 1: Search Step 3: Print or Text 12 Workflow Overview After Selection, OptimizeRx Instantly Returns Eligible Patient Support to Review & Auto - send to Pharmacy
Slide 13: Workflow Overview: Step 3 Print or Text
OTCQB: OPRX Step 3: Print or Text Step 1: Search Step 2: Selection 13 Workflow Overview We also have the ability to text & email patient Currently working with EHRs to integrate into patient’s portal. Full Savings Offer is Also Available to Print & Give to Patient
Slide 14: OptimizeRx Efficiently Supports & Benefits Key Stakeholders
OTCQB: OPRX Pharma Doctors EHR/EMRs Patients Pharmacists Promotional access to prescribers & patients at the point of prescript Information regarding drugs & the financial assistance available to patients, allowing doctors to choose their preferred drug while maintaining adherence Incremental revenu
Slide 15: Multiple Independent Studies Prove Outstanding ROI
OTCQB: OPRX 520% 1260% -800% -400% 0% 400% 800% 1200% 1600% eDetailing Display Paid Search eCoupon OptimizeRx eCoupon ROI vs. Other Promotional Tactics Lowest ROI Average ROI Highest ROI 15 Multiple Independent Studies Prove Outstanding ROI to Our Customers OptimizeRx eCoupon Most Effective Digital
Slide 16: Our Market Position
OTCQB: OPRX • Low fixed overhead SaaS model that offers high leveraged financial opportunity • Technology & support is in place to grow business 10 fold & beyond • Proven Benefits to all Stakeholders, including pharma • Proven value to doctors, patients, health systems & pharma with 500%+ ROI • Prov
Slide 17: Integrated in 350+ Electronic Health Record Providers
OTCQB: OPRX Our Technology is Integrated in 350+ Electronic Health Record (EHR) Providers & Growing Largest point of prescribe promotional network: 350+ EHRs , with 200+ EHRs exclusive to OptimizeRx , including Allscripts = high barriers to entry 17 August 2015: OptimizeRx & Allscripts expanded its
Slide 18: Our Clients Are the Leading Pharmaceutical Companies
OTCQB: OPRX Our Clients Are the Leading Pharmaceutical Companies in the World 18 Over 670 Rx brands that have copay coupons!
Slide 19: Focused on Growing Both Sides of the Business
OTCQB: OPRX Focused on Growing Both Sides of the Business Revenue Drivers More Brands More Platforms Primary Business Focus: More Brands & Platforms 19
Slide 20: How We Make Money
OTCQB: OPRX SampleMD Standard Pricing Metrics Set Up Fee (Plugging in disruptive technology) $25K Reporting $2K per month Cost Per Coupon Distribution (regardless if redeemed) $5.00 per coupon How We Make Money 20 NOTE: We do have Enterprise Wide discounts to incentivize Manufacturers to add portfol
Slide 21: Market Penetration: eCoupon vs. Traditional Rx Coupon Promotion
OTCQB: OPRX Market Penetration OptimizeRx eCoupon vs. Traditional Rx Coupon Promotion 5% Market Share Potential Scenario (in Millions) Revenue $30M Gross margin $15M SG&A $7.5M Net Income $7.5M As revenue grows, highly leveraged, low fixed costs generates cash 21 ~140 Million [CATEGOR Y NAME] [CATEG
Slide 22: Strategic Investment by WPP
OTCQB: OPRX “These new tools will help pharma better support physicians with the information they need, when they need it, through the channel they access most. “This will transform the physician - pharmaceutical relatio nship and positively impact people’s lives.” - Lynn O’Connor Vos, CEO of Grey H
Slide 23: Q4 2015 and Full Year 2015 Financial Highlights
OTCQB: OPRX $1.1 $2.0 $4.7 $6.5 $7.2 2011 2012 2013 2014 2015 Annual Revenue Growth ($ in millions) Q4 2015 and Full Year 2015 Financial Highlights • Net revenue was a record $ 2.02M in Q4, driving record full year revenue of $ 7.2M • Generated operating income , excluding non - cash expenses, of $3
Slide 24: Growth Drivers
OTCQB: OPRX Moving our existing clients to enterprise via proven ROI + leveraging WPP agencies management of hundreds of brands! Rolling our NextGen , PDR, Touchworks and other network & electronic platforms! Expanding to Patient Portals & Practice Management Systems. Commitments from expansion of e
Slide 25: Key Innovation Initiatives
OTCQB: OPRX “Dr. Smith would like to speak with you. Please hold...” Key Innovation Initiatives • Developing point of pharmacy network to automate savings & print for next fill • Animal Health point of care promotion • Launch Instant Rep on Demand • Implement support in patient portals • Build out p
Slide 26: Expanded Piggy-back Solutions Provide Further Promotional Revenue Opportunities
OTCQB: OPRX Expanded Piggy - back Solutions Provide Further Promotional Revenue Opportunities 26 Patient Education Provide customized patient education materials that can be printed during the e - prescribing process On - Demand Support Enable instant connection to your territory or remote rep — or
Slide 27: Expanded Piggy-back Solutions Provide Further Promotional Revenue Opportunities
OTCQB: OPRX Expanded Piggy - back Solutions Provide Further Promotional Revenue Opportunities 27
Slide 28: Key Takeaways
OTCQB: OPRX Key Takeaways • Huge Market – 2 Billion eRx transactional opportunities • Major Benefits to all Stakeholders – Beginning stages of helping deliver high value support into doctors workflow • Proven proprietary technology successfully implemented into largest promotional eRx network – Infi
Slide 29: Contact Us
OTCQB: OPRX Contact Us Company Contacts: William Febbo, CEO wfebbo@optimizerx.com 248 - 651 - 6568 Doug Baker, CFO dbaker@samplemd.com 248 - 651 - 6568 x807 Investor Relations Contact: Liolios Group Ron Both, Senior Managing Director oprx@liolios.com 949 - 574 - 3860 29 Headquarters: 400 Water Stree